327 related articles for article (PubMed ID: 15927244)
1. Endocannabinoid system and stress and anxiety responses.
Viveros MP; Marco EM; File SE
Pharmacol Biochem Behav; 2005 Jun; 81(2):331-42. PubMed ID: 15927244
[TBL] [Abstract][Full Text] [Related]
2. The role of the hippocampus in mediating emotional responses to nicotine and cannabinoids: a possible neural substrate for functional interactions.
Viveros MP; Marco EM; Llorente R; Lamota L
Behav Pharmacol; 2007 Sep; 18(5-6):375-89. PubMed ID: 17762508
[TBL] [Abstract][Full Text] [Related]
3. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
[TBL] [Abstract][Full Text] [Related]
4. Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience.
Campos AC; Ferreira FR; Guimarães FS; Lemos JI
Neuroscience; 2010 May; 167(2):238-46. PubMed ID: 20167262
[TBL] [Abstract][Full Text] [Related]
5. The endocannabinoid system: emotion, learning and addiction.
Moreira FA; Lutz B
Addict Biol; 2008 Jun; 13(2):196-212. PubMed ID: 18422832
[TBL] [Abstract][Full Text] [Related]
6. [Functional role of the endocannabinoid system in emotional homeostasis].
Marco EM; Viveros MP
Rev Neurol; 2009 Jan 1-15; 48(1):20-6. PubMed ID: 19145562
[TBL] [Abstract][Full Text] [Related]
7. The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction.
López-Moreno JA; González-Cuevas G; Moreno G; Navarro M
Addict Biol; 2008 Jun; 13(2):160-87. PubMed ID: 18422831
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling.
Patel S; Hillard CJ
J Pharmacol Exp Ther; 2006 Jul; 318(1):304-11. PubMed ID: 16569753
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system.
Zarrindast MR; Sarahroodi S; Arzi A; Khodayar MJ; Taheri-Shalmani S; Rezayof A
Behav Pharmacol; 2008 Oct; 19(7):716-23. PubMed ID: 18797248
[TBL] [Abstract][Full Text] [Related]
10. [The modulatory role of endocannabinoids in sleep].
Murillo-Rodríguez E
Rev Neurol; 2008 Feb 1-15; 46(3):160-6. PubMed ID: 18297624
[TBL] [Abstract][Full Text] [Related]
11. Interactions between the anxiogenic effects of CB1 gene disruption and 5-HT3 neurotransmission.
Mikics E; Vas J; Aliczki M; Halasz J; Haller J
Behav Pharmacol; 2009 May; 20(3):265-72. PubMed ID: 19421027
[TBL] [Abstract][Full Text] [Related]
12. Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice.
Haller J; Varga B; Ledent C; Barna I; Freund TF
Eur J Neurosci; 2004 Apr; 19(7):1906-12. PubMed ID: 15078564
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoid system and synaptic plasticity: implications for emotional responses.
Viveros MP; Marco EM; Llorente R; López-Gallardo M
Neural Plast; 2007; 2007():52908. PubMed ID: 17641734
[TBL] [Abstract][Full Text] [Related]
14. Role of lipids and lipid signaling in the development of cannabinoid tolerance.
Martin BR
Life Sci; 2005 Aug; 77(14):1543-58. PubMed ID: 15949820
[TBL] [Abstract][Full Text] [Related]
15. Cannabis and psychiatric disorders: it is not only addiction.
Leweke FM; Koethe D
Addict Biol; 2008 Jun; 13(2):264-75. PubMed ID: 18482435
[TBL] [Abstract][Full Text] [Related]
16. Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis.
Steiner MA; Wotjak CT
Prog Brain Res; 2008; 170():397-432. PubMed ID: 18655899
[TBL] [Abstract][Full Text] [Related]
17. The role of the endocannabinoid system in the regulation of hypothalamic-pituitary-adrenal axis activity.
Cota D
J Neuroendocrinol; 2008 May; 20 Suppl 1():35-8. PubMed ID: 18426497
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength.
Mackie K
Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S19-23. PubMed ID: 16570100
[TBL] [Abstract][Full Text] [Related]
19. Basic neuroanatomy and neuropharmacology of cannabinoids.
Breivogel CS; Sim-Selley LJ
Int Rev Psychiatry; 2009 Apr; 21(2):113-21. PubMed ID: 19367505
[TBL] [Abstract][Full Text] [Related]
20. Advances in the field of cannabinoid--opioid cross-talk.
Robledo P; Berrendero F; Ozaita A; Maldonado R
Addict Biol; 2008 Jun; 13(2):213-24. PubMed ID: 18482431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
